Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasisVallance, T., Zeuner, M.-T., Williams, H., Widera, D. ORCID: https://orcid.org/0000-0003-1686-130X and Vaiyapuri, S. ORCID: https://orcid.org/0000-0002-6006-6517 (2017) Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis. Mediators of inflammation, 2017. 9605894. ISSN 0962-9351
It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing. To link to this item DOI: 10.1155/2017/9605894 Abstract/SummaryPlatelets are non-nucleated blood cells that participate in a wide range of physiological and pathological functions. Their major role is mediating haemostasis and thrombosis. In addition to these classic functions, platelets have emerged as important players in the innate immune system. In particular, they interact with leukocytes, secrete pro- and anti-inflammatory factors, and express a wide range of inflammatory receptors including Toll-like receptors (TLRs) e.g. Toll-like receptor 4 (TLR4). TLR4, which is the most extensively studied TLR in nucleated cells, recognises lipopolysaccharides (LPS) that are compounds of the outer surface of Gram-negative bacteria. Unlike other TLRs, TLR4 is able to signal through both the MyD88-dependent and -independent signalling pathways. Notably, despite both pathways culminating in activation of transcription factors, TLR4 has a prominent functional impact on platelet activity, haemostasis, and thrombosis. In this review, we summarise the current knowledge on the TLR4 signalling in platelets, critically discuss its impact on platelet function, and highlight the open questions in this area.
Download Statistics DownloadsDownloads per month over past year Altmetric Deposit Details University Staff: Request a correction | Centaur Editors: Update this record |